(KTRA) MC $33 M--Cash $23 M-- 2 BIG Phase 3 Cancer Drugs ..Major Milestones imminent

(KTRA-DD) Market Cap only 34 million/ Cash balance 23 million / 2 Cancer Drugs to start Phase 3 imminent -HUGE commercial opp of over $1+ Billion / LOTS of upcoming Major milestones (see Chart below) including Phase 2 readout of the Newly diagnosed GBM Study = MASSIVE Underpriced stock with significant upside potential could run to 10 dollar and more on positive readouts .GL

Kintara Therapeutics (KTRA)

Market Cap $33 Million
Cash $23 Million
Price $1.35

Shares Out 24.6 Million


Company Presentation
https://d1io3yog0oux5.cloudfront.ne...pdf/Kintara+Therapeutics+Deck+08+31+FINAL.pdf


3 “Strong Buy” Healthcare Stocks Under $5 That Could Go Boom..
https://finance.yahoo.com/news/3-strong-buy-healthcare-stocks-193054154.html